These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34369213)

  • 1. Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management.
    Zhao L; Yu S; Wang L; Zhang X; Hou J; Li X
    Scand J Clin Lab Invest; 2021 Oct; 81(6):488-493. PubMed ID: 34369213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17, rather than Th1 cell proportion, is closely correlated with elevated disease severity, higher inflammation level, and worse prognosis in sepsis patients.
    Liu Y; Wang X; Yu L
    J Clin Lab Anal; 2021 May; 35(5):e23753. PubMed ID: 33704828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
    Giamarellos-Bourboulis EJ; Norrby-Teglund A; Mylona V; Savva A; Tsangaris I; Dimopoulou I; Mouktaroudi M; Raftogiannis M; Georgitsi M; Linnér A; Adamis G; Antonopoulou A; Apostolidou E; Chrisofos M; Katsenos C; Koutelidakis I; Kotzampassi K; Koratzanis G; Koupetori M; Kritselis I; Lymberopoulou K; Mandragos K; Marioli A; Sundén-Cullberg J; Mega A; Prekates A; Routsi C; Gogos C; Treutiger CJ; Armaganidis A; Dimopoulos G
    Crit Care; 2012 Aug; 16(4):R149. PubMed ID: 22873681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.
    Liu X; Shen Y; Li Z; Fei A; Wang H; Ge Q; Pan S
    BMC Anesthesiol; 2016 Jul; 16(1):46. PubMed ID: 27473112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
    Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
    J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between Jun N-terminal kinase pathway-associated phosphatase and Th1 cell or Th17 cell in sepsis and their potential roles in clinical sepsis management.
    Yu D; Peng X; Li P
    Ir J Med Sci; 2021 Aug; 190(3):1173-1181. PubMed ID: 33083958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
    Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
    Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality.
    Chen D; Wu X; Yang J; Yu L
    Exp Ther Med; 2019 Oct; 18(4):2984-2992. PubMed ID: 31555383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
    Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
    J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 relates to Th17 cells and serves as a potential biomarker for sepsis inflammation, organ dysfunctions and mortality risk.
    Zhang W; Chen B; Chen W
    J Clin Lab Anal; 2022 May; 36(5):e24309. PubMed ID: 35325494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke.
    Chen X; Zhang X; Lan L; Xu G; Li Y; Huang S
    J Clin Lab Anal; 2021 Sep; 35(9):e23903. PubMed ID: 34273195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombo-inflammatory biomarkers to predict sepsis outcome.
    Efat A; Shoeib SA; Arafa AF; Dawod AA; Abd ElHafez MA; Abd ElMohsen EA; Eladly HF; Ibrahim RA; Elkholy A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048561. PubMed ID: 34647483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu B; Ren H; Chen J
    Biomark Med; 2021 Sep; 15(13):1177-1186. PubMed ID: 34406030
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
    Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
    J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
    Geboers DG; de Beer FM; Tuip-de Boer AM; van der Poll T; Horn J; Cremer OL; Bonten MJ; Ong DS; Schultz MJ; Bos LD
    Intensive Care Med; 2015 Jul; 41(7):1281-90. PubMed ID: 26100127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile.
    Tsirigotis P; Chondropoulos S; Frantzeskaki F; Stamouli M; Gkirkas K; Bartzeliotou A; Papanikolaou N; Atta M; Papassotiriou I; Dimitriadis G; Dimopoulou I
    J Crit Care; 2016 Apr; 32():9-15. PubMed ID: 26726794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
    El-Mekkawy MS; Saleh NY; Sonbol AA
    Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.